To minimize certain negative side effects of radiation in the treatment of prostate cancer, a new technology proven to reduce the incidence of radiation damage to the rectum and reduce potential adverse effects of radiation on men’s sexual function was introduced at South County Hospital. This is the first time the device, SpaceOAR hydrogel, has been used in Rhode Island.
The SpaceOAR hydrogel device is a protective spacer placed between the prostate and rectum, preventing high dose radiation from reaching the organ-at-risk (rectum) while targeting the prostate. This type of cancer treatment is offered at South County Radiation Therapy.
The hydrogel spacer is made of similar material used in brain surgery, cardiology, and ophthalmology. For this use, it has been clinically proven to reduce the risk of side effects from radiation treatment for prostate cancer. The spacer remains in place for the duration of the three month radiation treatment before it is absorbed into the body and excreted through the urine.
SpaceOAR was approved by the Food and Drug Administration (FDA) In April 2015.
To learn more about South County Urology and the treatment capabilities at South County Hospital, such as SpaceOAR and da Vinci Xi robotic-assisted surgery, please visit the South County Urology webpage.